James W. Sharpe
Keine laufenden Positionen mehr
Karriereverlauf von James W. Sharpe
Ehemalige bekannte Positionen von James W. Sharpe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Präsident | - | 25.01.2006 |
Ausbildung von James W. Sharpe
| Rochester Christian University | Masters Business Admin |
| Union College (New York) | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| President | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
- Börse
- Insiders
- James W. Sharpe
- Erfahrung